Transient Knockdown of Anopheles Stephensi LRIM1 Using RNAi Increases Plasmodium Falciparum Sporozoite Salivary Gland Infections

Overview

Journal Malar J

Publisher Biomed Central

Specialty Tropical Medicine

Date 2021 Jun 27

PMID 34174879

Citations 6

Authors

Peter F Billingsley

Kasim I George

Abraham G Eappen

Robert A Harrell 2nd

Robert Alford

Tao Li

Sumana Chakravarty

B Kim Lee Sim

Stephen L Hoffman

David A OBrochta

Affiliations

Soon will be listed here.

Abstract

Background: Plasmodium falciparum (Pf) sporozoites (PfSPZ) can be administered as a highly protective vaccine conferring the highest protection seen to date. Sanaria® PfSPZ vaccines are produced using aseptically reared Anopheles stephensi mosquitoes. The bionomics of sporogonic development of P. falciparum in A. stephensi to fully mature salivary gland PfSPZ is thought to be modulated by several components of the mosquito innate immune system. In order to increase salivary gland PfSPZ infections in A. stephensi and thereby increase vaccine production efficiency, a gene knock down approach was used to investigate the activity of the immune deficiency (IMD) signaling pathway downstream effector leucine-rich repeat immune molecule 1 (LRIM1), an antagonist to Plasmodium development.

Methods: Expression of LRIM1 in A. stephensi was reduced following injection of double stranded (ds) RNA into mosquitoes. By combining the Gal4/UAS bipartite system with in vivo expression of short hairpin (sh) RNA coding for LRIM1 reduced expression of LRIM1 was targeted in the midgut, fat body, and salivary glands. RT-qPCR was used to demonstrate fold-changes in gene expression in three transgenic crosses and the effects on P. falciparum infections determined in mosquitoes showing the greatest reduction in LRIM1 expression.

Results: LRIM1 expression could be reduced, but not completely silenced, by expression of LRIM1 dsRNA. Infections of P. falciparum oocysts and PfSPZ were consistently and significantly higher in transgenic mosquitoes than wild type controls, with increases in PfSPZ ranging from 2.5- to tenfold.

Conclusions: Plasmodium falciparum infections in A. stephensi can be increased following reduced expression of LRIM1. These data provide the springboard for more precise knockout of LRIM1 for the eventual incorporation of immune-compromised A. stephensi into manufacturing of Sanaria's PfSPZ products.

Citing Articles

Combination of computational techniques and RNAi reveal targets in Anopheles gambiae for malaria vector control.

Adedeji E, Beder T, Damiani C, Cappelli A, Accoti A, Tapanelli S PLoS One. 2024; 19(7):e0305207.

PMID: 38968330 PMC: 11226046. DOI: 10.1371/journal.pone.0305207.

Mosquito midgut stem cell cellular defense response limits Plasmodium parasite infection.

Barletta A, Smith J, Burkart E, Bondarenko S, Sharakhov I, Criscione F Nat Commun. 2024; 15(1):1422.

PMID: 38365823 PMC: 10873411. DOI: 10.1038/s41467-024-45550-2.

A recombinant Aspergillus oryzae fungus transmitted from larvae to adults of Anopheles stephensi mosquitoes inhibits malaria parasite oocyst development.

Kianifard L, Rafiqi A, Akcakir O, Aly A, Billingsley P, Uysal S Sci Rep. 2023; 13(1):12177.

PMID: 37500682 PMC: 10374630. DOI: 10.1038/s41598-023-38654-0.

Novel systems to study vector-pathogen interactions in malaria.

Parres-Mercader M, Pance A, Gomez-Diaz E Front Cell Infect Microbiol. 2023; 13:1146030.

PMID: 37305421 PMC: 10253182. DOI: 10.3389/fcimb.2023.1146030.

Cryopreservation of Anopheles stephensi embryos.

James E, Wen Y, Overby J, Pluchino K, McTighe S, Matheny S Sci Rep. 2022; 12(1):43.

PMID: 34997079 PMC: 8741979. DOI: 10.1038/s41598-021-04113-x.

References

Roestenberg M, Bijker E, Sim B, Billingsley P, James E, Bastiaens G . Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites. Am J Trop Med Hyg. 2012; 88(1):5-13. PMC: 3541746. DOI: 10.4269/ajtmh.2012.12-0613. View

Garver L, Bahia A, Das S, Souza-Neto J, Shiao J, Dong Y . Anopheles Imd pathway factors and effectors in infection intensity-dependent anti-Plasmodium action. PLoS Pathog. 2012; 8(6):e1002737. PMC: 3369948. DOI: 10.1371/journal.ppat.1002737. View

Hodgson S, Juma E, Salim A, Magiri C, Njenga D, Molyneux S . Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya. Malar J. 2015; 14:182. PMC: 4416324. DOI: 10.1186/s12936-015-0671-x. View

Jongo S, Church L, Mtoro A, Chakravarty S, Ruben A, Swanson P . Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults. Clin Infect Dis. 2019; 71(11):2849-2857. PMC: 7947995. DOI: 10.1093/cid/ciz1152. View

Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M . Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015; 83(5):2185-96. PMC: 4399069. DOI: 10.1128/IAI.03069-14. View

Richie T, Billingsley P, Sim B, James E, Chakravarty S, Epstein J . Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine. 2015; 33(52):7452-61. PMC: 5077156. DOI: 10.1016/j.vaccine.2015.09.096. View

Kennerdell J, Carthew R . Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell. 1999; 95(7):1017-26. DOI: 10.1016/s0092-8674(00)81725-0. View

Jaramillo-Gutierrez G, Rodrigues J, Ndikuyeze G, Povelones M, Molina-Cruz A, Barillas-Mury C . Mosquito immune responses and compatibility between Plasmodium parasites and anopheline mosquitoes. BMC Microbiol. 2009; 9:154. PMC: 2782267. DOI: 10.1186/1471-2180-9-154. View

Weiss D, Bertozzi-Villa A, Rumisha S, Amratia P, Arambepola R, Battle K . Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect Dis. 2020; 21(1):59-69. PMC: 7505634. DOI: 10.1016/S1473-3099(20)30700-3. View

10.

Hodgson S, Juma E, Salim A, Magiri C, Kimani D, Njenga D . Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection. Front Microbiol. 2015; 5:686. PMC: 4264479. DOI: 10.3389/fmicb.2014.00686. View

11.

Baxter R, Steinert S, Chelliah Y, Volohonsky G, Levashina E, Deisenhofer J . A heterodimeric complex of the LRR proteins LRIM1 and APL1C regulates complement-like immunity in Anopheles gambiae. Proc Natl Acad Sci U S A. 2010; 107(39):16817-22. PMC: 2947905. DOI: 10.1073/pnas.1010575107. View

12.

Billingsley P, Maas C, Olotu A, Schwabe C, Garcia G, Rivas M . The Equatoguinean Malaria Vaccine Initiative: From the Launching of a Clinical Research Platform to Malaria Elimination Planning in Central West Africa. Am J Trop Med Hyg. 2020; 103(3):947-954. PMC: 7470544. DOI: 10.4269/ajtmh.19-0966. View

13.

Olotu A, Urbano V, Hamad A, Eka M, Chemba M, Nyakarungu E . Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men. Am J Trop Med Hyg. 2017; 98(1):308-318. PMC: 5928718. DOI: 10.4269/ajtmh.17-0449. View

14.

Bastiaens G, van Meer M, Scholzen A, Obiero J, Vatanshenassan M, van Grinsven T . Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial. Am J Trop Med Hyg. 2015; 94(3):663-673. PMC: 4775905. DOI: 10.4269/ajtmh.15-0621. View

15.

Dimopoulos G, Richman A, Muller H, Kafatos F . Molecular immune responses of the mosquito Anopheles gambiae to bacteria and malaria parasites. Proc Natl Acad Sci U S A. 1997; 94(21):11508-13. PMC: 23521. DOI: 10.1073/pnas.94.21.11508. View

16.

Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A . Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017; 542(7642):445-449. PMC: 10906480. DOI: 10.1038/nature21060. View

17.

Devon R, Porteous D, Brookes A . Splinkerettes--improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res. 1995; 23(9):1644-5. PMC: 306912. DOI: 10.1093/nar/23.9.1644. View

18.

Misquitta L, Paterson B . Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): a role for nautilus in embryonic somatic muscle formation. Proc Natl Acad Sci U S A. 1999; 96(4):1451-6. PMC: 15483. DOI: 10.1073/pnas.96.4.1451. View

19.

Lyke K, Ishizuka A, Berry A, Chakravarty S, DeZure A, Enama M . Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci U S A. 2017; 114(10):2711-2716. PMC: 5347610. DOI: 10.1073/pnas.1615324114. View

20.

Sissoko M, Healy S, Katile A, Omaswa F, Zaidi I, Gabriel E . Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect Dis. 2017; 17(5):498-509. PMC: 6803168. DOI: 10.1016/S1473-3099(17)30104-4. View